StockVS

TriplePoint Venture Growth BDC Corp. (TPVG) 股票分析

金融服务

TriplePoint Venture Growth BDC Corp.

$5.65

+$0.11 (+1.99%)

最后更新: 2026年5月26日

价格走势

最新新闻

新闻由第三方来源提供。不构成投资建议。

分析

公司概述

TriplePoint Venture Growth BDC Corp. operates as a business development company that specializes in providing debt financing to venture capital-backed companies situated in the growth stage. The firm focuses on offering growth capital loans, secured and customized loans within the venture growth space, catering specifically to businesses requiring capital to expand their operations. This entity functions within the Financial Services sector, specifically under the Asset Management industry, where it manages capital to generate returns for shareholders through lending activities. With a market capitalization of $204.48M and annual revenue of $90.36M, the company represents a mid-sized player in the specialized lending landscape, though specific employee count data is not disclosed in public filings. These valuation and revenue figures indicate that the company maintains a significant operational footprint while leveraging its niche focus on venture-backed growth firms to differentiate itself from traditional banking institutions.

财务健康

The company reported a trailing twelve-month revenue of $90.36M and net income of $49.21M, while EBITDA data is not available for analysis in the current reporting period. The substantial gap between total revenue and net income, resulting in a profit margin of 54.5%, reveals a highly efficient cost structure where operating expenses are kept to a minimum relative to the income generated. This efficiency is further highlighted by an operating margin of 59.0% and a gross margin of 100.0%, suggesting that the majority of revenue flows directly to the bottom line after covering the cost of funds and direct operational costs. The firm generated free cash flow of $32.39M, which provides essential financial flexibility to service debt obligations, fund new lending activities, or return capital to shareholders without relying on external financing. However, the balance sheet is heavily leveraged, evidenced by total debt of $469.08M compared to cash reserves of $20.36M and a debt-to-equity ratio of 132.65, indicating a reliance on borrowed capital to support its asset base. Liquidity is robust, supported by a current ratio of 3.40, which suggests the company holds sufficient current assets to cover its short-term liabilities with a comfortable margin of safety. Management effectiveness is quantified by a return on equity of 14.1% and a return on assets of 5.4%, demonstrating the ability to generate substantial returns on the equity invested and a solid yield on the total asset portfolio despite the high leverage.

估值评估

The stock trades at a trailing twelve-month P/E ratio of 4.14 and a forward P/E of 6.70, implying that the market expects earnings to grow significantly in the coming periods to justify the higher forward multiple. The price-to-book ratio stands at 0.58, indicating that the market values the company at a discount to its book value, a common characteristic for highly leveraged financial firms where equity value is net of substantial debt obligations. Alternative valuation metrics such as the price-to-sales ratio of 2.26 and an EV/EBITDA of N/A provide additional context, with the P/S ratio reflecting the premium investors are willing to pay for each dollar of sales given the specialized nature of the lending business. Regarding price metrics, the 52-week high was $7.53 and the 52-week low was $4.48, placing the current trading environment within a range defined by these extremes and reflecting recent market sentiment. The beta of 1.38 indicates that the stock exhibits higher volatility than the broader market, moving 38% more than the market average in response to systemic risks and interest rate fluctuations.

Growth & Income

Revenue growth over the last year declined by 12.7% year-over-year, while earnings growth data is not available, suggesting that recent revenue contraction has not yet fully impacted reported net income or that the earnings figure remains stable due to the high-margin structure. For a company with such a high dividend yield of 20.0%, the payout ratio of 88.5% indicates that the firm distributes the vast majority of its earnings to shareholders, leaving limited room for organic reinvestment in the current period. The combination of a declining revenue trend and a payout ratio near 90% suggests that income distribution is the primary driver of shareholder returns rather than capital appreciation or aggressive expansion. Overall, the company presents a profile focused on generating high current income for investors, albeit with recent revenue headwinds and a balance sheet that prioritizes debt distribution over equity growth.

同行比较

TriplePoint Venture Growth BDC Corp. (TPVG) 在资产管理行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
TriplePoint Venture Growth BDC Corp. TPVG $229.38M 5.4
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

资产管理行业平均市盈率为28.6倍。TriplePoint Venture Growth BDC Corp.的市盈率为5.4。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

公司简介以英文显示。

访问官网 →

关键指标

市值
$229.38M
市盈率
5.38
52周最高
$7.53
52周最低
$4.48
平均成交量
459.93K
Beta系数
1.34
股息率
16.64%

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States